Top 19 Intrepida Bio investors
The most complete profiles first. Showing 19 of 19.
Eric YoungVerified
Venture Capital, Founder, Investor · United Kingdom
SeedSeries BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Filanet, Hallo and 85 more
Verified email available
Guy RussoVerified
Venture Capital, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Jared NewmanVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Jonathan LeffVerified
Venture Capital, Investor · United States
SeedSeries BHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more
Verified email available
Joydeep BhattacharyyaVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceCybersecurityPortfolio: BoostUp.ai, Node, OncoResponse, Hallo and 84 more
Verified email available
Laura ChauVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Sarah BhagatVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Tim ShannonVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 83 more
Verified email available
Alan ColowickVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Hootan RashidifardVerified
Venture Capital · United States
AdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Jason PittsVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Mike PowellVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Maha Katabi, PhD, CFA
Hedge Fund, Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more
Contact details available
Nandu Anilal
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Contact details available
Perry Nisen
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Rayfe Gaspar
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Contact details available
Alfred Yue
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Byron Ling
Venture Capital · United States
AdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Contact details available
Hooman Shahlavi
Hedge Fund, Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Ladder10
- Synthekine10
- Astra10
- Synova Life Sciences10
- Sounding Board10
- OncoResponse10
- Juno10
- Agile Stacks10
- Taptap Send10
- Sleek10
- Vineti10
Frequently asked questions
How many Intrepida Bio investors are on Angel Roster?
Angel Roster lists 19 Intrepida Bio investors. 12 of them (63%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (19), Private Equity Firms (6) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Intrepida Bio investors invest in?
Among those that list a stage, the most common are Series B (9), Series A (8) and Seed (5).
Where are Intrepida Bio investors based?
Most are based in the United States (17), Canada (1) and the United Kingdom (1).
Which companies have Intrepida Bio investors backed?
The most-backed portfolio companies among them are Ladder (10), Synthekine (10), Astra (10), Synova Life Sciences (10) and Sounding Board (10).
How do I contact Intrepida Bio investors?
Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.